148 related articles for article (PubMed ID: 14979258)
1. VaxGen releases interim results of the clinical trial of its experimental vaccine.
Can HIV AIDS Policy Law Rev; 2002 Mar; 6(3):48-9. PubMed ID: 14979258
[No Abstract] [Full Text] [Related]
2. HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen.
Adis International Ltd
Drugs R D; 2003; 4(4):249-53. PubMed ID: 12848591
[TBL] [Abstract][Full Text] [Related]
3. Thai HIV vaccine trial prompts angry exchanges.
Nelson K
Lancet; 2004 Jan; 363(9405):299. PubMed ID: 14753209
[No Abstract] [Full Text] [Related]
4. AIDSVAX is safe, but efficacy question remains. VaxGen founder discusses quest for AIDS vaccine.
Francis DP
AIDS Alert; 2001 Nov; 16(11):141-2, 147. PubMed ID: 11692665
[No Abstract] [Full Text] [Related]
5. Large-scale HIV vaccine trial to begin this summer.
Highleyman L
BETA; 1998 Jul; ():3. PubMed ID: 11365557
[TBL] [Abstract][Full Text] [Related]
6. Large HIV vaccine trial begins.
Santiago L
GMHC Treat Issues; 1998 Oct; 12(10):1-5. PubMed ID: 11365900
[TBL] [Abstract][Full Text] [Related]
7. Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
Burton DR; Desrosiers RC; Doms RW; Feinberg MB; Gallo RC; Hahn B; Hoxie JA; Hunter E; Korber B; Landay A; Lederman MM; Lieberman J; McCune JM; Moore JP; Nathanson N; Picker L; Richman D; Rinaldo C; Stevenson M; Watkins DI; Wolinsky SM; Zack JA
Science; 2004 Jan; 303(5656):316. PubMed ID: 14726576
[No Abstract] [Full Text] [Related]
8. AIDSVAX. VaxGen.
Billich A
Curr Opin Investig Drugs; 2001 Sep; 2(9):1203-8. PubMed ID: 11717805
[TBL] [Abstract][Full Text] [Related]
9. Impending AIDS vaccine trial opens old wounds.
Balter M
Science; 1998 Jan; 279(5351):650. PubMed ID: 9471726
[No Abstract] [Full Text] [Related]
10. First AIDS vaccine trial launched.
Science; 1998 Jun; 280(5370):1697. PubMed ID: 9660708
[No Abstract] [Full Text] [Related]
11. HIV vaccines. Viral envelope fails to deliver?
Bolognesi DP; Matthews TJ
Nature; 1998 Feb; 391(6668):638-9. PubMed ID: 9490406
[No Abstract] [Full Text] [Related]
12. Lessons from the RV144 Thai phase III HIV-1 vaccine trial and the search for correlates of protection.
Kim JH; Excler JL; Michael NL
Annu Rev Med; 2015; 66():423-37. PubMed ID: 25341006
[TBL] [Abstract][Full Text] [Related]
13. Vaccine passes another test.
AIDS Patient Care STDS; 2001 Jul; 15(7):404. PubMed ID: 11526904
[No Abstract] [Full Text] [Related]
14. Controversial HIV vaccine enters phase III trials amid skepticism.
AIDS Alert; 1998 Dec; 13(12):133-4, 136. PubMed ID: 11366059
[TBL] [Abstract][Full Text] [Related]
15. Lessons from failure--preparing for future HIV-1 vaccine efficacy trials.
Graham BS; Mascola JR
J Infect Dis; 2005 Mar; 191(5):647-9. PubMed ID: 15688276
[No Abstract] [Full Text] [Related]
16. AIDSVAX results: an answer, or just more questions?
Johnston R
AIDS Patient Care STDS; 2003 Feb; 17(2):47-51. PubMed ID: 12650142
[TBL] [Abstract][Full Text] [Related]
17. AIDSVAX VaxGen.
Billich A
Curr Opin Investig Drugs; 2004 Feb; 5(2):214-21. PubMed ID: 15043397
[TBL] [Abstract][Full Text] [Related]
18. The RV144 Thai HIV vaccine trial.
Plotkin SA
Hum Vaccin; 2010 Feb; 6(2):159. PubMed ID: 20431337
[No Abstract] [Full Text] [Related]
19. Funding support lacking in search for HIV vaccine.
AIDS Alert; 1999 Jan; 14(1):5-7. PubMed ID: 11366091
[TBL] [Abstract][Full Text] [Related]
20. HIV vaccine AIDSVAX.
Drugs R D; 1999 Jun; 1(6):456-8. PubMed ID: 10566083
[No Abstract] [Full Text] [Related]
[Next] [New Search]
